Feasibility Study of Physiotherapy for Functional Motor Symptoms
Launched by UNIVERSITY COLLEGE, LONDON · Oct 22, 2014
Trial Information
Current as of June 15, 2025
Completed
Keywords
ClinConnect Summary
Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.
Treatment as Usual group -
1. Participants will be directed to online patient information resources (www.neurosymptoms.org)
2. Participants will be placed on the waiting list to be assessed for the inpatient treatment programme for functional symptoms at The National Hospital for Neurology and Neurosurgery. The waitlist is currently gr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A clinically established diagnosis of functional motor symptoms according to the Fahn-Williams criteria.
- • Diagnostic investigations have come to an end.
- • The patient accepts the diagnosis of functional motor symptoms.
- • Symptom duration of at least six months.
- • Symptoms must be sufficient to cause significant distress (subjectively described by the patient) or impairment in social, occupational or other important areas of functioning.
- Exclusion Criteria:
- • Unable to understand English.
- • Pain, fatigue or dissociative seizures is the predominant symptom.
- • Prominent untreated axis 1 disorders (e.g. anxiety or depression).
- • Level of disability prevents participation in a 5 day outpatient programme (Barthel Index score less than 25/100)
- • Patient unable to attend 5 consecutive days.
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Glenn Nielsen
Principal Investigator
UCL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials